Moloney Securities Asset Management, LLC Alkermes Plc. Transaction History

Moloney Securities Asset Management, LLC

  • $706 Million
  • Q4 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 28, 2022
SELL
$21.47 - $32.08 $796,537 - $1.19 Million
-37,100 Closed
0 $0
Q3 2021

Oct 27, 2021
BUY
$23.37 - $32.13 $867,027 - $1.19 Million
37,100 New
37,100 $1.14 Million
Q1 2020

May 08, 2020
SELL
$13.06 - $21.24 $140,577 - $228,627
-10,764 Closed
0 $0
Q4 2019

Feb 06, 2020
SELL
$17.29 - $21.74 $300,223 - $377,493
-17,364 Reduced 61.73%
10,764 $220,000
Q3 2019

Nov 01, 2019
BUY
$19.51 - $24.28 $548,777 - $682,947
28,128 New
28,128 $549,000

Others Institutions Holding ALKS

# of Institutions
375
Shares Held
173M
Call Options Held
231K
Put Options Held
158K
View Full List

About Alkermes plc.

ALKS Quotes by TradingView
  • Ticker ALKS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 164,254,000
  • Market Cap $5.8B
  • Description
  • Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...
More about ALKS
Track This Portfolio

Track Moloney Securities Asset Management, LLC Portfolio

Follow Moloney Securities Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Moloney Securities Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Moloney Securities Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email